| For: | Jiang YL, Fu XY, Yin ZH. Retrospective efficacy analysis of olaparib combined with bevacizumab in the treatment of advanced colorectal cancer. World J Gastrointest Surg 2023; 15(5): 906-916 [PMID: 37342840 DOI: 10.4240/wjgs.v15.i5.906] | 
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v15/i5/906.htm | 
| Number | Citing Articles | 
| 1 | 
                             
                                            Patrycja Gralewska, Łukasz Biegała, Arkadiusz Gajek, Izabela Szymczak-Pajor, Agnieszka Marczak, Agnieszka Śliwińska, Aneta Rogalska. Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines. International Journal of Molecular Sciences 2025; 26(2): 693 doi: 10.3390/ijms26020693
                                         
                                     | 
                    
| 2 | 
                             
                                            Ruizhi Fan, Teng Xu, Yuting Kuang. Research on lncRNA CTBP1-DT as a potential therapeutic target to regulate cell function in colorectal cancer. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01085-y
                                         
                                     | 
                    
